These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 23680130)

  • 1. A small jab - a big effect: nonspecific immunomodulation by vaccines.
    Benn CS; Netea MG; Selin LK; Aaby P
    Trends Immunol; 2013 Sep; 34(9):431-9. PubMed ID: 23680130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune system under stress: travel and immune reactivity].
    Mueller RL
    Fortschr Med; 1995 Feb; 113(6):63-6. PubMed ID: 7721223
    [No Abstract]   [Full Text] [Related]  

  • 3. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related decline in immunity: implications for vaccine responsiveness.
    Kumar R; Burns EA
    Expert Rev Vaccines; 2008 May; 7(4):467-79. PubMed ID: 18444893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific effects of vaccines and the reduction of mortality in children.
    Shann F
    Clin Ther; 2013 Feb; 35(2):109-14. PubMed ID: 23375475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
    van Riet E; Ainai A; Suzuki T; Kersten G; Hasegawa H
    Adv Drug Deliv Rev; 2014 Jul; 74():28-34. PubMed ID: 24862579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ; Weiner DB
    Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
    Mortellaro A; Ricciardi-Castagnoli P
    Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
    Fujihashi K; Kiyono H
    Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health and vaccines--immune responses in developed versus poor countries.
    Markus MB
    S Afr Med J; 2003 Nov; 93(11):834-5. PubMed ID: 14677503
    [No Abstract]   [Full Text] [Related]  

  • 12. Decoding the human immune system to transform the future of global disease prevention and control.
    Koff WC; Schenkelberg T
    Expert Rev Vaccines; 2016 Oct; 15(10):1235-6. PubMed ID: 27010379
    [No Abstract]   [Full Text] [Related]  

  • 13. The molecular and cellular correlates of immunological phenomena. Contrasting two explanatory pathways.
    Vaz N
    Braz J Med Biol Res; 1996 May; 29(5):545-53. PubMed ID: 9033803
    [No Abstract]   [Full Text] [Related]  

  • 14. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of inflammatory diseases by pathogens: lipids and the immune system.
    van der Kleij D; Yazdanbakhsh M
    Eur J Immunol; 2003 Nov; 33(11):2953-63. PubMed ID: 14579263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Memory: The Latest Frontier of Adjuvanticity.
    Töpfer E; Boraschi D; Italiani P
    J Immunol Res; 2015; 2015():478408. PubMed ID: 26380322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex correlates of protection after vaccination.
    Plotkin SA
    Clin Infect Dis; 2013 May; 56(10):1458-65. PubMed ID: 23386629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of formation of postvaccinal immunity in the population of one-company towns and rural settlements 1].
    Boev MV; Moev VM; Borisov SD
    Gig Sanit; 2012; (3):19-21. PubMed ID: 23088113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On immunity against infections and vaccines: credo 2004.
    Zinkernagel RM; Hengartner H
    Scand J Immunol; 2004; 60(1-2):9-13. PubMed ID: 15238068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.